Hypha Labs, Inc. (FUNI)
OTCMKTS · Delayed Price · Currency is USD
0.0187
0.00 (0.00%)
Jul 30, 2026, 4:00 PM EST

Hypha Labs Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
-----2.5
Revenue Growth
------2.74%
Gross Profit
-----0.72
Operating Income
-1.91-2.94-1.76-0.26-1.93-0.77
Net Income
-2.16-3.1-0.790.25-2.25-0.69
Earnings Per Share
-0.01-0.02-0.010.00-0.03-0.01
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
0.080.040.090.270.060.32
Total Debt
1.811.651.142.292.352.35
Net Cash (Debt)
-1.73-1.61-1.05-2.02-2.29-2.03
Net Cash Growth
------
Net Cash Per Share
-0.01-0.01-0.01-0.02-0.03-0.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-0.54-0.38-1.030.11-0.18-0.14
Capital Expenditures
-0.03-0.03-0.03---0.06
Free Cash Flow
-0.57-0.41-1.060.11-0.18-0.19
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
-----28.56%
Operating Margin
------30.85%
Pretax Margin
------27.42%
Profit Margin
------27.42%
FCF Margin
------7.67%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PE Ratio
---5.22--
P/FCF Ratio
---11.46--
PS Ratio
-----1.20